Recombinantly engineered human proteins : transforming the treatment of psoriasis

Psoriasis is a chronic, inflammatory disease with lesions that produce considerable physical discomfort and often lead to substantial disruption in patients' daily activities. The use of currently available, nonspecific, systemic immunosuppressive therapies for patients with moderate to severe...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 105(2002), 2 vom: 01. Nov., Seite 105-16
1. Verfasser: Gottlieb, Alice B (VerfasserIn)
Weitere Verfasser: Bos, Jan D
Format: Aufsatz
Sprache:English
Veröffentlicht: 2002
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Review Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Cytokines Diphtheria Toxin Immunoglobulin G Interleukin-2 OKT4A monoclonal antibody Receptors, Tumor Necrosis Factor mehr... Recombinant Fusion Proteins Recombinant Proteins denileukin diftitox 25E79B5CTM Infliximab B72HH48FLU Daclizumab CUJ2MVI71Y Alefacept ELK3V90G6C Etanercept OP401G7OJC galiximab S9OX9692ZB